Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis

…, AJ Van Der Kooi, M De Visser, D Verbaan… - Annals of …, 2011 - Wiley Online Library
Objective: Several studies have suggested an increased frequency of variants in the gene
encoding angiogenin (ANG) in patients with amyotrophic lateral sclerosis (ALS). Interestingly, …

The identification of Parkinson's disease subtypes using cluster analysis: a systematic review

…, WJ Heiser, JN Kok, D Verbaan… - Movement …, 2010 - Wiley Online Library
The clinical variability between patients with Parkinson's disease (PD) may point at the
existence of subtypes of the disease. Identification of subtypes is important, since a focus on …

A systematic review and meta-analysis of Woven EndoBridge single layer for treatment of intracranial aneurysms

…, JP Peluso, J Daams, D Verbaan… - Interventional …, 2020 - journals.sagepub.com
Background and purpose The Woven EndoBridge is an intrasaccular device for the treatment
of intracranial aneurysms. The first generation consisted of a high-profile double-layer braid…

Patient-reported autonomic symptoms in Parkinson disease

D Verbaan, J Marinus, M Visser, SM van Rooden… - Neurology, 2007 - AAN Enterprises
Objective: There is a wide range of autonomic symptoms (AS) in Parkinson disease (PD), but
the full spectrum has never been evaluated with a validated instrument and in comparison …

Cognitive impairment in Parkinson's disease

D Verbaan, J Marinus, M Visser… - Journal of Neurology …, 2007 - jnnp.bmj.com
… Figure 3 (A–D) Clinical characteristics of subgroups of patients based on quartiles of SCales
for Outcomes in PArkinson’s disease-COGnition (SCOPA-COG) scores. 1st–4th quartile, …

The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone

RJ Molenaar, D Verbaan, S Lamba, C Zanon… - Neuro …, 2014 - academic.oup.com
… 1D). Patients with only an IDH1 mutation did not have significantly different survival from …
2B–D). A multivariate Cox regression analysis confirmed the independent prognostic …

Clinical subtypes of Parkinson's disease

…, P Martínez‐Martín, M Visser, D Verbaan… - Movement …, 2011 - Wiley Online Library
The clinical heterogeneity of Parkinson's disease (PD) may point at the existence of subtypes.
Because subtypes likely reflect distinct underlying etiologies, their identification may …

Ultra-early tranexamic acid after subarachnoid haemorrhage (ULTRA): a randomised controlled trial

…, GJE Rinkel, YB Roos, WP Vandertop, D Verbaan… - The Lancet, 2021 - thelancet.com
Background In patients with aneurysmal subarachnoid haemorrhage, short-term antifibrinolytic
therapy with tranexamic acid has been shown to reduce the risk of rebleeding. However, …

A comparative study of odor identification and odor discrimination deficits in Parkinson's disease

S Boesveldt, D Verbaan, DL Knol… - … : official journal of the …, 2008 - Wiley Online Library
The aim of this study was to compare the characteristics of odor discrimination and odor
identification deficits in a large population of patients with Parkinson's disease (PD) and to …

Nighttime sleep problems and daytime sleepiness in Parkinson's disease

D Verbaan, SM van Rooden, M Visser… - Movement …, 2008 - Wiley Online Library
Our objective is to evaluate nighttime sleep problems (NSP) and daytime sleepiness (DS) in
patients with Parkinson's disease (PD) compared to controls, and to assess relations with …